Análisis de la cuota de mercado y oportunidades de medicamentos para trastornos neurológicos (2025-2031)
Neurological Disorder Drugs Market Report Analysis
Neurological Disorder Drugs Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Neurocrine Biosciences, Inc.,
- Pfizer Inc.,
- Biogen Inc.,
- Teva Pharmaceutical Industries Ltd.,
- AcelRx Pharmaceuticals, Inc.,
- Eli Lilly and Company,
- Adamas Pharmaceuticals, Inc.,
- BioMarin Pharmaceutical Inc
- AstraZeneca plc,
Regional Overview
- América del Norte
- Europa
- Asia-Pacífico
- América del Sur y Central
- Medio Oriente y África
Market Segmentation
By Tipo de fármaco
- antipsicótico
- antiepiléptico
- anticolinérgico
- analgésico
- hipnótico y sedante
- anticoagulante
- antihipertensivo
By Tipo de enfermedad
- epilepsia
- enfermedad de Parkinson
- enfermedad de Alzheimer
- enfermedad cerebrovascular
- esclerosis múltiple
By Canal de Distribución
- Farmacias Hospitalarias
- Farmacias Minoristas
- Farmacias Online.
By Geografía
- América del Norte
- Europa
- Asia-Pacífico
- América del Sur y Central
Get Free Sample For